American Trust’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
VCM
VPM
American Trust's AMGN Position: Q1 2026 in Review
American Trust reduced its Amgen (AMGN) stake by 19% in Q1 2026, selling an estimated $62.4K and leaving 731 shares worth $257K. The position accounts for 0.02% of the portfolio, ranked #257.
American Trust first reported a position in AMGN in Q1 2022 and has held it in 11 quarters since. The position peaked at $361K in Q4 2022. 3,131 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.
- American Trust held 731 shares of Amgen worth $257K as of Q1 2026.
- American Trust sold 175 Amgen shares in Q1 2026, an estimated $62.4K.
- Amgen made up 0.02% of American Trust's portfolio in Q1 2026, its #257 holding.
- American Trust first reported a position in Amgen in Q1 2022 and has held it in 11 quarters since.
- American Trust's Amgen position peaked at $361K in Q4 2022.
- 3,131 funds tracked by Wall St. Rank held Amgen as of Q1 2026.
Based on American Trust's 13F filing for Q1 2026, filed 1 May 2026.